Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration

Por Björnsson, Marcus A, Simonsson, Ulrika S H
Publicado em 2011

Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution

Por Clewe, Oskar, Karlsson, Mats O., Simonsson, Ulrika S. H.
Publicado no J Pharmacokinet Pharmacodyn (2015)

Performance of Nonlinear Mixed Effects Models in the Presence of Informative Dropout

Por Björnsson, Marcus A., Friberg, Lena E., Simonsson, Ulrika S. H.
Publicado no AAPS J (2014)

Residual Spinal Cord Compression Following Hemilaminectomy and Mini-Hemilaminectomy in Dogs: A Prospective Randomized Study

Por Svensson, Gustaf, Simonsson, Ulrika S. H., Danielsson, Fredrik, Schwarz, Tobias
Publicado no Front Vet Sci (2017)

Improved power for TB Phase IIa trials using a model-based pharmacokinetic–pharmacodynamic approach compared with commonly used analysis methods

Por Svensson, Robin J., Gillespie, Stephen H., Simonsson, Ulrika S. H.
Publicado no J Antimicrob Chemother (2017)

A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells—using rifampicin as an example

Por Clewe, Oskar, Goutelle, Sylvain, Conte, John E., Simonsson, Ulrika S. H.
Publicado no Eur J Clin Pharmacol (2015)

A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions

Por Wicha, Sebastian G., Chen, Chunli, Clewe, Oskar, Simonsson, Ulrika S. H.
Publicado no Nat Commun (2017)

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro

Por Clewe, Oskar, Aulin, Linda, Hu, Yanmin, Coates, Anthony R. M., Simonsson, Ulrika S. H.
Publicado no J Antimicrob Chemother (2016)

Population Pharmacokinetics of Rifapentine and Its Primary Desacetyl Metabolite in South African Tuberculosis Patients

Por Langdon, Grant, Wilkins, Justin, McFadyen, Lynn, McIlleron, Helen, Smith, Peter, Simonsson, Ulrika S. H.
Publicado em 2005

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients

Por Wilkins, Justin J, Langdon, Grant, McIlleron, Helen, Pillai, Goonaseelan, Smith, Peter J, Simonsson, Ulrika S H
Publicado em 2011

Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicin

Por Zhang, Chao, Denti, Paolo, Decloedt, Eric, Maartens, Gary, Karlsson, Mats O, Simonsson, Ulrika S H, McIlleron, Helen
Publicado em 2012

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

Por Clewe, Oskar, Wicha, Sebastian G, de Vogel, Corné P, de Steenwinkel, Jurriaan E M, Simonsson, Ulrika S H
Publicado no J Antimicrob Chemother (2018)

Population pharmacokinetics of edoxaban in patients with symptomatic deep‐vein thrombosis and/or pulmonary embolism—the Hokusai‐VTE phase 3 study

Por Niebecker, Ronald, Jönsson, Siv, Karlsson, Mats O., Miller, Raymond, Nyberg, Joakim, Krekels, Elke H. J., Simonsson, Ulrika S. H.
Publicado no Br J Clin Pharmacol (2015)

A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

Por Svensson, Robin J., Aarnoutse, Rob E., Diacon, Andreas H., Dawson, Rodney, Gillespie, Stephen H., Boeree, Martin J., Simonsson, Ulrika S.H.
Publicado no Clin Pharmacol Ther (2017)

Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

Por Wicha, Sebastian G., Clewe, Oskar, Svensson, Robin J., Gillespie, Stephen H., Hu, Yanmin, Coates, Anthony R.M., Simonsson, Ulrika S.H.
Publicado no Clin Pharmacol Ther (2018)

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Por Wilkins, Justin J., Savic, Radojka M., Karlsson, Mats O., Langdon, Grant, McIlleron, Helen, Pillai, Goonaseelan, Smith, Peter J., Simonsson, Ulrika S. H.
Publicado em 2008

Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients

Por Jönsson, Siv, Davidse, Alistair, Wilkins, Justin, Van der Walt, Jan-Stefan, Simonsson, Ulrika S. H., Karlsson, Mats O., Smith, Peter, McIlleron, Helen
Publicado em 2011

Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models

Por Chen, Chunli, Wicha, Sebastian G., de Knegt, Gerjo J., Ortega, Fatima, Alameda, Laura, Sousa, Veronica, de Steenwinkel, Jurriaan E. M., Simonsson, Ulrika S. H.
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)

Improving treatment outcome assessment in a mouse tuberculosis model

Por Mourik, Bas C., Svensson, Robin J., de Knegt, Gerjo J., Bax, Hannelore I., Verbon, Annelies, Simonsson, Ulrika S. H., de Steenwinkel, Jurriaan E. M.
Publicado no Sci Rep (2018)

Effects of Four Different Meal Types on the Population Pharmacokinetics of Single-Dose Rifapentine in Healthy Male Volunteers

Por Zvada, Simbarashe P., Van Der Walt, Jan-Stefan, Smith, Peter J., Fourie, P. Bernard, Roscigno, Giorgio, Mitchison, Denis, Simonsson, Ulrika S. H., McIlleron, Helen M.
Publicado em 2010